Abstract
The objective of this article is to provide an illustrative tutorial highlighting the utility of 18F-FDG PET/CT imaging to detect the spectrum of manifestations in patients with Langerhans cell histiocytosis. FDG PET/CT is a powerful tool for making an early diagnosis; it allows higher diagnostic confidence with regard to lesions, measuring the extent of disease (staging) and assessing disease activity, and is consequently useful for evaluating the response to therapy in patients with Langerhans cell histiocytosis.
Similar content being viewed by others
References
Chu T, Jaffe R. The normal Langerhans cell and the LCH cell. Br J Cancer Suppl. 1994;23:S4–10.
Freebody J, Wegner EA, Rossleigh MA. 2-deoxy-2-((18)F)fluoro-d-glucose positron emission tomography/computed tomography imaging in paediatric oncology. World J Radiol. 2014;6:741–55.
Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2009;52:97–101.
Steiner M, Prayer D, Asenbaum S, Prosch H, Minkov M, Unger E, et al. Modern imaging methods for the assessment of Langerhans’ cell histiocytosis-associated neurodegenerative syndrome: case report. J Child Neurol. 2005;20:253–7.
Weitzman S, Egeler RM. Langerhans cell histiocytosis: update for the pediatrician. Curr Opin Pediatr. 2008;20:23–9.
Da Costa CET, Annels NE, Faaij CMJM, Forsyth RG, Hogendoorn PCW, Egeler RM. Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis. J Exp Med. 2005;201:687–93.
Khung S, Budzik J-F, Amzallag-Bellenger E, Lambilliote A, Soto Ares G, Cotten A, et al. Skeletal involvement in Langerhans cell histiocytosis. Insights Imaging. 2013;4:569–79.
Schmidt S, Eich G, Geoffray A, Hanquinet S, Waibel P, Wolf R, et al. Extraosseous Langerhans cell histiocytosis in children. Radiogr Rev Publ Radiol Soc N Am Inc. 2008;28:707–26 (quiz 910–1).
Kazama T, Swanston N, Podoloff DA, Macapinlac HA. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging. 2005;32:1406–11.
Querings K, Starz H, Balda B-R. Clinical spectrum of cutaneous Langerhans’ cell histiocytosis mimicking various diseases. Acta Derm Venereol. 2006;86:39–43.
Juvet SC, Hwang D, Downey GP. Rare lung diseases III: pulmonary Langerhans’ cell histiocytosis. Can Respir J J Can Thorac Soc. 2010;17:e55–62.
Mueller RJ, Siegel A, Seltzer M, McKnight TA. Langerhans cell histiocytosis of the auditory canal detected by 18F-FDG PET/CT. Clin Nucl Med. 2012;37:908–9.
Herwig MC, Wojno T, Zhang Q, Grossniklaus HE. Langerhans cell histiocytosis of the orbit: five clinicopathologic cases and review of the literature. Surv Ophthalmol. 2013;58:330–40.
Yi X, Han T, Zai H, Long X, Wang X, Li W. Liver involvement of Langerhans’ cell histiocytosis in children. Int J Clin Exp Med. 2015;8:7098–106.
Turpin S, Carret A-S, Dubois J, Buteau C, Patey N. Isolated thymic Langerhans cell histiocytosis discovered on F-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT). Pediatr Radiol. 2015;45:1870–3.
Iqbal Y, Al-Shaalan M, Al-Alola S, Afzal M, Al-Shehri S. Langerhans cell histiocytosis presenting as a painless bilateral swelling of the parotid glands. J Pediatr Hematol Oncol. 2004;26:276–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest statement
None of the authors have any conflict of interest.
Financial disclosures
None of the authors have any financial disclosures.
About this article
Cite this article
Agarwal, K.K., Seth, R., Behra, A. et al. 18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations. Jpn J Radiol 34, 267–276 (2016). https://doi.org/10.1007/s11604-016-0517-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-016-0517-7